Newstral
Article
bizjournals.com on 2015-05-19 18:40
Cynosure stock hits new high on fat-reducing device approval
Related news
- Stereotaxis device gets FDA approvalbizjournals.com
- TNon Invasive Fat Removal Surgery Market Size, In-Deep Analysis Details, Application, Regional Demand, and Forecast, 2028 | Cynosure, Candela, AbbViethetechtalk.org
- New tobacco-heating device gains FDA approvalstaradvertiser.com
- Weightlifting better at reducing heart fat than aerobic exerciseThe Jerusalem Post (JPost.com)
- Concussion device gets FDA approval for marketingbizjournals.com
- Pollution reducing device launchedtimesofmalta.com
- Allergan receives FDA approval for electrical dry-eye deviceocregister.com
- Israeli-led research team says curbing liver fat key to reducing obesity riskstimesofisrael.com
- GIsraeli PixCell Medical scores Australia Gov. approval for blood diagnostic device at point-of-caregeektime.com
- MLa Jolla stock jumps 16% after FDA approvalmarketwatch.com
- MDynavax stock surges 18% on hepatitis B vaccine approvalmarketwatch.com
- MSeattle Genetics' stock rises on approval of bladder cancer drugmarketwatch.com
- Popular fat-reducing procedure can make you fatter. Woman sues over rare side effect.The Wichita Eagle
- Artio Medical hits major milestone: FDA approval for its first medical devicebizjournals.com
- MNeovasc's stock rockets after 'Reducer' granted Breakthrough Device designationmarketwatch.com
- MAbbVie stock ticks higher on FDA approval of psoriasis treatmentmarketwatch.com
- MNeurocrine's stock is up on FDA approval of Parkinson's drugmarketwatch.com
- MAdamis Pharma stock skyrockets after rival EpiPen product gets FDA approvalmarketwatch.com
- MGW Pharma's stock rallies after its cannabinoid drug gets a new FDA approvalmarketwatch.com
- MCytoSorbents' stock jumps on FDA authorization for its device in COVID-19 patientsmarketwatch.com